Showing results (181-190 of 831) with videos related to

Sort By:
Pageof 84
Cancer|March 21, 2009
Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapyRavin Garg, Hagop Kantarjian, Deborah Thomas, et al.
Blood|July 3, 2010
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosisAlbert Gutierrez, Renee C Tschumper, Xiaosheng Wu, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 27, 2007
Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemiaWilliam Martin, Roshini Abraham, Tait Shanafelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2015
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK InhibitorsSutapa Sinha, Justin Boysen, Michael Nelson, et al.
Cancer|June 24, 2010
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimenDeborah Thomas, Susan O'Brien, Stefan Faderl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Significance of increasing levels of minimal residual disease in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic responseHagop M Kantarjian, Jianqin Shan, Daniel Jones, et al.
Cancer|January 27, 2010
Adult acute lymphoblastic leukemia: concepts and strategiesStefan Faderl, Susan O'Brien, Ching-Hon Pui, et al.
Cancer|March 29, 2002
Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemiaSrdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemiaMoshe Talpaz, Ashok Rakhit, Karen Rittweger, et al.
Blood|April 15, 2022
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trialTait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, et al.
Pageof 84